Microbiological Assessment of Commercially Available Quinine Syrup and Water for Injections in Dar Es Salaam, Tanzania by Mwambete, K D et al.
Mwambete et al 
Trop J Pharm Res, October 2009; 8 (5):  441 
Tropical Journal of Pharmaceutical Research, October 2009; 8 (5): 441-447 
© Pharmacotherapy Group,  
Faculty of Pharmacy, University of Benin,  
Benin City, 300001 Nigeria.  
All rights reserved. 
 




Microbiological Assessment of Commercially Available 
Quinine Syrup and Water for Injections in Dar Es 
Salaam, Tanzania 
 
Kennedy D Mwambete1*, Mary Justin-Temu2 and Fatema S 
Fazleabbas3 
1
Department of Pharmaceutical Microbiology, 
2
Department of Pharmaceutics Muhimbili University of Health & Allied 
Sciences, School of Pharmacy, P.O. Box 65013, 
3






Purpose: To conduct microbiological assessment of commercially available quinine syrups and water for 
injection in Dar es Salaam, Tanzania. 
Methods:  This was a cross-sectional study conducted in Dar es Salaam Region. Samples of quinine 
syrups (QNSs) and water for injection (WFI) of different batches were randomly purchased. Each QNS 
was inspected for label disclosure, and physicochemical properties were examined by the use of sense 
of organs and pH meter. Isolation and quantification of microbial contaminants from each sample was 
preceded by 24 - 48 h incubation at 37 ºC, and the microbial contaminants were expressed as colony 
forming unit per millilitre (cfu/ml). Microbiological identification of contaminants was performed by 
examination of colony morphologies and growth characteristics. Gram staining technique, as well as 
biochemical and serological tests were also conducted for further identification. Albino rabbits were used 
for the pyrogen test to determine the presence of microbial contamination in WFI.  
Results: Twenty-four samples of QNS underwent label disclosure, physical-chemical and 
microbiological assessments. All QNS samples complied with the guidelines and microbial limits as per 
United States Pharmacopoeia (USP). All batches of WFI were found to be microbiologically 
contaminated, revealing average microbial counts of 87, 94 and  100 cfu/ml, and this was buttressed by 
pyrogen test, with the animals showing temperature rise of 1.0, 2.2 and 2.4 ºC, respectively. 
Conclusion:  The QNS products available in the Dar es Salaam market were of good microbial quality. 
However, WFI products were microbiologically contaminated. We recommend that regulatory authorities 
in Tanzania should diligently enforce regulatory control of the products to assure consumer safety.  
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INTRODUCTION 
 
Malaria has been a leading source of mortality 
and morbidity for Tanzanian children 
particularly for under 5-year-old [1]. 
Consequently, adequate disease 
management in primary health care units is 
the basis for malaria control which is in line 
with national and global malaria control 
strategies [2-4].  On the other hand, accurate 
diagnosis and treatment cannot be 
overemphasized for effective malaria control. 
Quinine (QN) is a drug of choice for treatment 
of Plasmodium falciparum malaria. In addition 
to its anti-malarial activity, the drug also 
possesses antipyretic, analgesic and anti-
inflammatory properties [5]. Quinine was 
previously superseded by chloroquine in 
terms of usage, but because of the rise of 
chloroquine resistance, its use has increased 
and currently is available on prescription only 
basis. It can be administered orally, 
intramuscularly, or intravenously. However, 
the use of intramuscular QN in children may 
cause abscess, and therefore, this route of 
administration is discouraged [6].  As a result 
of its characteristic bitter taste, QN is 
preferably used in children in the form of 
syrup [7] but poorly prepared quinine syrups 
(QNSs) are subject to microbial 
contaminations, which may ultimately 
contribute to secondary bacterial infections, 
especially as the immune system of children 
is immature.  
 
Undoubtedly, the use of water in the 
pharmaceutical industry is indispensable, 
especially in pharmaceutical liquid 
preparations. Not only is water used as a 
component of various pharmaceutical 
formulations, but also for cleaning and rinsing 
of medical devices and appliances. One of the 
most important and delicate use of water is in 
the production of water for injection (WFI), 
which essentially is pure water (H2O). 
Production of WFI or any other pharmaceutical 
products intended for parenteral application is 
widely recognized as a critical process, which 
requires strict adherence to good 
manufacturing practices (GMP) and quality 
control. Such pharmaceutical products must 
be free from pyrogens, which can originate 
from Gram-negative or Gram-positive bacteria, 
viruses and fungi, or from any other viable 
microorganisms [7-10]. This study, therefore, 
assessed the microbiological quality of 
commercially available QNSs and WFI 
available in the market in Dar es Salaam, the 




Study design and area 
 
The study was conducted in Dar es Salaam 
Region, across all the three districts of the 
region, viz, Ilala, Kinondoni and Temeke. Eight 
different batches/brands of QNSs were 
purchased, and at least one batch of WFI was 
also randomly purchased from at least one 
pharmacy in each district.  
 
Inspection of label disclosure and 
physicochemical analysis 
 
All the samples were inspected for any 
physical irregularities/defects. Colour, odour, 
taste and appearance of the QNSs were 
assessed by the use of sense of appropriate 
organs. The pH of each sample was 
determined with a pH meter (Jenway-3505, 
UK). Label information such as batch number, 
expiry date, manufacturing date, direction for 
use and ingredient composition were recorded. 
WFIs were packed in sealed plastic 
containers. 
 
Preparation of samples and assessment of 
microbial quality 
 
The following selective and non-selective 
culture media were employed for quantification 
and isolation of the microbial contaminants: 
nutrient agar (NA, Oxoid, England), 
Saboraud’s dextrose agar (SDA, Pronadisa, 
Spain) thiosulphate-citrate-bile-sucrose agar 
(TCBS) and MacConkey agar (MCA, Roth, 
German). One millilitre-aliquots of each 
sample of QNS was directly spread-plated 
onto the sterile NA and SDA, and incubated for 
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24 - 48 hours at 37 ºC. This temperature was 
selected because fungal dimorphic growth is 
not demonstrated above differential incubation 
temperature (35 ºC), thus facilitating the quan-
tification of yeast cells rather than the mycelia 
forms that grow better at lower temperatures 
[11].  
 
Prior to observation and recording of any 
microbial contamination, serial dilution was 
performed whenever deemed necessary by 
dispersing QNS in WFI. Quantification of 
viable microbial counts was conducted and 
expressed as colony forming unit per millilitre 
(cfu/ml). Therefore, WFI alone was also 
included as negative control. These 
procedures were conducted in duplicate and 
repeated twice, and the cfu/ml was expressed 
as a mean. Pure and single microbial colonies 
were sub-cultured onto solid and liquid media, 
incubated at 37 ºC for 24 hours and finally 
stored at 4 ºC until further use. 
 
Microbiological identification of contami-
nants 
 
Identification of the isolated microbial 
contaminants was preliminarily performed by 
macroscopic examination of the microbial 
morphology of the pure cultures of isolated 
microorganisms and other typical growth 
characteristics on non-selective, selective, and 
differential culture media, such as lactose 
fermentation on MCA, and TCBS, and 
haemolysis in blood agars, complemented with 
Gram staining technique. Gram-negative 
curved rods with distinctive darting motility, 
when observed, were immobilized by Vibrio 
cholerae O-group I antiserum (Difco, USA). 
Furthermore, microbial identity was confirmed 
by conventional microbiological (biochemical 
and physiological) tests [11-12]. 
 
Pyrogen test  
 
Following the observation of microbial 
contaminations in WFIs that were employed as 
negative controls, pyrogen test was performed 
on them (WFIs). Four healthy albino rabbits of 
the same age weighing 2.1 - 2.7 kg were 
employed in each assay. Prior to conducting 
the pyrogen test, the animals were trained for 
3 days consecutively by parenterally 
administering them with 10ml/kg of sterile 
saline solution. Using a digital thermometer 
(Mode ECT-1, accuracy + 0.1 ºC), rectal 
temperature was taken thrice each at 0, 15, 60 
and 360 minutes. The test commenced by first 
recording the rabbits’ body baseline 
temperature and then each animal was 
intravenously administered with 10ml/kg of 
WFI. A rise of temperature by 0.5 ºC was 
considered positive [13]. Other criteria for 
pyrogen testing were applied in line with 
approved guidelines [9-10, 14-15]. 
 
Ethical issues  
 
This study was conducted in partial fulfillment 
of the Bachelor of Pharmacy degree for one of 
the authors (FSF) and funded by the Ministry 
of Higher Education Science and Technology 
(Tanzania), and ethical clearance was given 
by the Muhimbili University of Health and 




The data obtained were analyzed using the 
Statistical Package for the Social Sciences 
software (SPSS+ 15.0, 1999, SPSS Inc., 
Chicago, IL, USA). Differences of means for 
cfu/ml and rabbits’ body temperature rise for 
each test were compared using Student t-test 




Twenty four samples of commercially available 
QNSs were subjected to label disclosure 
inspection, physical-chemical examination and 
microbiological assessment. The results are 
shown in Table 1. All the samples complied 
with the requirement for microbial limit (≤ 100 
cfu/ml) [9,14]. Microbiological assessment of 3 
batches of WFI revealed heavy microbial 
contaminations: 87, 100 and 94 cfu/ml for the 
first, second and third batches, respectively.  
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Microbiological tests revealed the presence of Staphylococcus spp in all the batches of WFIs, 
Table 1: Description of test quinine syrups and results of assessment of pH and organoleptic properties 
 
Syrup type Man. date Expiry date Origin Batchno. Colour Smell pH 
QB Jul 2006 Jul 2008 Nairobi 6H28 Green Fair 2.95 
QB Aug 2006 Aug 2008 Nairobi 6H39 Green Fair 2.98 
QB Feb 2007 Feb 2009 Moshi ONPS 7005 Orange Fair 3.16 
QB Jan 2007 Jan 2010 Nairobi 48414 Color less Fair 2.99 
QB Feb 2007 Jan 2009 Nairobi 7B168 Green Fair 2.96 
QB Aug 2006 Jul 2009 Nairobi 6H29 Green Fair 2.94 
QB Nov 2006 Oct 2008 DAR 6004 Green Fair 3.32 
QB Mar 2007 Feb 2009 Moshi QNPS 7011 Orange Fair 3.25 
QB Feb  2007 Jan 2009 Nairobi 7B168 Green Fair 2.81 
QH Oct  2006 Sept 2008 Kampala 4506 Light Pink Fair 6.03 
QB Feb 2007 Jan 2009 Nairobi 7B170 Green Fair 2.80 
QB Feb 2007 Jan 2009 Moshi QNPS 7001 Orange Fair 3.28 
QB Jan 2007 Dec 2009 Nairobi 7A126 Green Fair 3.03 
QB Dec 2006 Nov 2008 DAR 6005 Green Fair 3.34 
QB Jan 2007 Jan 2009 Moshi QNPS 7002 Orange Fair 3.28 
QB Jan  2007 Dec 2008 Nairobi 7B168 Green Fair 2.78 
QB Feb 2007 Jan 2009 Nairobi 7B171 Green Fair 2.82 
QH Sept 2006 Aug 2008 Kampala 4505 Light Pink Fair 6.05 
QB Mar 2007 Feb 2009 Moshi QNPS 7004 Orange Fair 3.22 
QB Mar 2007 Feb 2010 Nairobi 7A129 Green Fair 3.18 
QB Jan  2007 Dec 2009 Nairobi 7A127 Green Fair 3.02 
QB Jan 2007 Dec 2010 DAR 6008 Green Fair 3.36 
QB Feb 2007 Jan 2010 Moshi QNPS 7012 Orange Fair 3.29 
QB Nov 2006 Oct 2008 DAR 6003 Green Fair 3.35 
Key: DAR = Dar es Salaam; Man = manufacture; QB = quinine bisulphate; QH = quinine  hydrochloride 
 
while Bacillus sublitis, E. coli and Vibrio spp. 
were isolated only in some of the batches. ‘ 
 
The results of the pyrogen test, which was 
specifically performed to ascertain the 
presence of both pyrogenic substances and 
viable microbial contaminants in WFIs, are 
summarised in Table 2. The rabbit pyrogen 
test confirmed our observation of probable 
contamination of the WFI samples as all the 
animals showed a rise of temperature of as 
high as 4 ºC following parenteral admini-
stration with WFI. Mean temperature rise of 1, 
2.4 and 2.2 ºC were recorded for the first, 
second and third batches of WFI, respectively 
(Table 2). Temperature rise in each case was 




The present study has demonstrated that 
commercial QNSs in the Dar es Salaam 
market are of good microbiological quality. Out 
of the 24 assayed samples, none has revealed 
any microbial contamination upon being sub-
cultured onto non-selective as well as selective 
culture media. As expected, low water activity, 
which characterises almost all syrup 
preparations, did not favor microbial 
proliferation in these products [15]. 
Furthermore, QNS provides an unfavourable 
environment for microbial growth, due to its 
acidity with pH ranging from 2.78 to 6.2 [9]
 
(as 
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indicated in Table 1). This level of acidity does 
not permit a number of non-acidophilic 
microorganisms to survive. However,  
 Table 2: Pyrogen tests on water for injection (WFI) in Albino rabbits. 
 
Recorded temperature 
Batch  Rabbit 
Weight 
(kg) 0 min 15 min 60 min 360 min 
Result 
1st 1 2.45 38.6 38.7 38.9 39.3 Positive 
 2 2.50 38.7 39.7 39.8 39.9 Positive 
 3 2.66 37.7 37.7 37.9 39.5 Positive 
 4 2.12 38.1 38.2 38.6 38.8 Positive 
2nd 1 2.45 38.2 38.3 38.5 38.9 Positive 
 2 2.50 38.0 38.2 38.6 39.0 Positive 
 3 2.66 37.6 38.6 39.5 40.6 Positive 
 4 2.12 37.3 40.3 40.9 41.3 Positive 
3rd 1 2.45 38.6 39.8 39.9 41.4 Positive 
 2 2.50 38.2 38.9 39.8 40.7 Positive 
 3 2.66 38.1 38.5 38.8 39.8 Positive 
 4 2.12 37.7 38.0 38.7 39.7 Positive 
 
 
acidophiles would strive for survival in this kind 
of environment. If this had happened, the 
microbial by-products would have altered the 
pH, thus creating a more favourable condition 
for growth of other kinds of microorganisms 
[16]. Absence of detectable microbial 
contamination is indicative of adherence to 
GMPs by both local and foreign manufacturers 
of the products. 
 
A previous unpublished study by us showed a 
high level of microbial contaminants in 
extemporaneously prepared QNSs in hospital 
pharmacies in Tanzania. This motivated us to 
embark on the present study. Moreover, it was 
found that some of the QNSs bore labels 
indicating a shelf-life of 2 years or longer (see 
Table 1). However, it was observed in a 
previous study that such a long shelf-life in 
poor storage conditions may lead to 
decomposition of some ingredients in the 
formulation[10], resulting in pH change and 
ultimately, microbial contaminations. 
 
The results for WFI were surprising since 
preparations intended for parenteral or 
ophthalmic administration should be strictly 
sterile though this may alter during use [8,10]. 
Additionally, WFI should be free from 
pyrogens. The fact that microbial 
contamination was found in the WFI batches 
indicates that the WFI products were indeed 
substandard. According to the Parenteral Drug 
Association, during in-process quality control 
procedures, a sampling error of 1cfu/10ml is 
an acceptable action limit, but if action limits 
are exceeded, then immediate action must be 
taken to rectify the problem [8]. However, 
sterility test, on its own, does not provide a 
guarantee as to the sterility of a batch, but it is 
an additional check, and continued compliance 
with the test does gives confidence as to the 
efficacy of a sterilization or aseptic process. 
Failure to conduct sterility test, despite its 
shortcomings, may have important legal and 
moral consequences [18].  
  
The rabbit pyrogen test, based on the 
intravenous injection of sterile solutions, has 
been employed for many years and it is still 
valid for the quality control of parenteral 
preparations [14,19-20]. Regardless of the 
existing gap between the pyrogenicity in 
rabbits and the expected pyrogenicity in 
humans as a consequence of species 
differences, rabbit pyrogen test continues to 
have one major advantage over other pyrogen 
test systems in that it can best replicate and 
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show the production of fever in humans. 
Moreover, the test not only detects a variety of 
injectable substances that can trigger fever but 
also microbial endotoxins or endogenous 
pyrogenic cytokines [21]. In this study, the test 
has proved to be useful and accurate, because 
apart from pyrogens, microorganisms were 
also isolated from the WFIs. In accordance 
with the requirements and definitions of WFI 
[8-9,16], the findings of this study show the 
presence of microbial contamination in the 
WFI preparations tested, thus rendering them 
unfit for the intended purposes. One of the 
findings of great concern is the presence of 
viable and potentially pathogenic 
microorganisms, namely, Staphylococcus 
aureus and E. coli [22]. The microbial 
contamination may be attributable to poor 
adherence to GMP, quality control procedures 
and inadequate post-marketing surveillance of 





This study has revealed that QNSs that were 
commercially available in the Dar es Salaam 
market, Tanzania were microbiologically fit for 
use. However, WFI were found to be 
microbiologically contaminated. The isolation 
of potentially pathogenic opportunistic 
microorganisms such as S. aureus and E. coli 
calls for more stringent measures during the 
production of the products as well as effective 
post-marketing surveillance. We, therefore, 
recommend that the Tanzania Food and Drugs 
Authority should improve on its regulatory 
control of WFI products prior releasing them 
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